Hereditary genetic testing can be a powerful tool when managing patients with breast cancer and may inform surgical decisions. Receive STAT results in 7 days on average.*
Transforming breast cancer care¹
Hereditary cancer genetic testing can potentially allow for more personalized care options and targeted therapies 1,2, which may improve outcomes in BRCA-positive patients, which can even extend to their families. Family members of patients with hereditary breast cancer who undergo genetic testing have the potential opportunity for early detection and prevention of cancer.
As many as 1 in 8 breast cancer patients has a pathogenic gene variant that may impact clinical management recommendations.2,4,5
Help support cancer prevention and early detection for your patient’s family members.
If your patient has a positive result, their family members can have up to a 50% risk of having the same variant.
Invitae offers family variant testing for all blood relatives of patients who undergo hereditary cancer genetic testing at Invitae and have a positive result.
Now they know: Real stories
“
Once I found out I had [a] BRCA1 [gene variant], I just decided. I have a chance to do something.”
- Sarah
Read Sarah's story
